assessed by open field test every five weeks. Oral rotenone treatment at 5 mg/kg after 15 weeks caused significant reduction in both distance moved and movement duration as compared with the vehicle-treated controls (p<0.05). Data (mean ± SEM) was analyzed using Student's unpaired t-test; *, P<0.05. * Both isoform bands of V-ATPase H were used for quantification.
5
Supplementary Tables   Supplementary Table S1 Tests of Between-Subjects Effects aging also had no significant effect on these three locomotor parameters. However, the combination of genotype and rotenone treatment had a significant effect on distance moved and movement duration, but not rearing frequency.
9
Supplementary cumulative distance moved or rearing frequency. The combination of genotype with aging also had no significant effect on these three locomotor parameters. However, the combination of genotype and rotenone treatment had a significant effect on these three cumulative locomotor parameters.
